M ANUSCRIPT ACCEPTED Page 1 M ANUSCRIPT ACCEPTED ACCEPTED
MANUSCRIPT Yancy, CW et al. 2013 ACCF/AHA Heart Failure Guideline Page 1 2013 …

To assess the feasibility of diuretic discontinuetion in patients with stable congestive heart
failure (CHF) and to identify risk factors for subsequent development of congestion, a …

The intestinal absorption of digoxin is essentially a passive non-saturable diffusion process,
although a saturable carrier-mediated component also plays an important role. The …

Digoxin remains an important therapeutic option for the outpatient management of patients
with chronic symptomatic heart failure caused by systolic dysfunction. Randomized control …

Background Rintatolimod is a selective TLR3 agonist, which has demonstrated clinical
activity for ME/CFS in Phase II and Phase III double-blind, placebo-controlled, randomized …

A defective myocardial energy supply—due to lack of substrates and/or essential cofactors
and a poor utilization efficiency of oxygen 3-may be a common final pathway in the …

Purpose The Kantrowitz CardioVADTM (KCV) is an electrically powered, pneumatically
driven circulatory assist device which provides diastolic augmentation and systolic …

Several retrospective studies have raised concerns regarding digoxin therapy in select
subgroups of heart failure patients. To assess the impact of digoxin therapy on outcomes in …

Digitalis glycosides exert a positive inotropic effect, ie an increase in myocardial contractility
associated with a prolongation of relaxation period, and glycosides lower the heart rate …

Objectives. This study was conducted to determine the efficacy and safety of long-term
treatment with the orally active dopamine agonist ibopamine in patients with mild to …